Role of the essential thiol group in the thiol‐activated cytolysin from Clostridium perfringens

FEBS Journal - Tập 167 Số 3 - Trang 425-430 - 1987
Machiko Iwamoto1, Yoshiko Ohno‐Iwashita1, Shinji Ando1
1Department of Biochemistry, Tokyo Metropolitan Institute of Gerontology, Tokyo

Tóm tắt

A hemolysin, θ‐toxin, produced by Clostridium perfringens has one cysteinyl residue in the free thiol form which is essential for its hemolytic activity. The cysteinyl residue was shown to be located at a position about 5 kDa from the C terminus of the molecule by the method of cysteine‐specific chemical cleavage. Modification of the residue with a thiol‐blocking agent, 5,5′‐dithiobis(2‐nitrobenzoic acid), reduced the binding affinity of the toxin to sheep erythrocytes to 1/100 that of intact toxin, resulting in a failure of binding at low cell concentrations (0.5%). Thus the failure of hemolysis at low cell concentrations is primarily ascribed to a decreased affinity of the toxin for erythrocytes. Effects of the modification on the lytic processes were examined using high cell concentrations where considerable amounts of modified toxin bound to the cells. The modified toxin hemolyzes erythrocytes once it binds to them; however, the efficiency of hemolysis is reduced by the modification. These, and additional results indicating that modification alters the sensitivity of toxin molecules to protease digestion, show that thiol‐modification inactivates the toxin by affecting both binding and the subsequent lytic processes, probably through a conformational change introduced in the toxin molecules.

Từ khóa


Tài liệu tham khảo

Alouf J. E., 1976, The specificity and action of animal, bacterial and plant toxins, 221

10.1016/0304-4157(74)90007-0

Smyth C. J., 1978, Bacterial toxins and cell membranes, 129

10.1016/0163-7258(80)90045-5

Cowell J. L., 1977, Infect. Immun., 16, 397, 10.1128/iai.16.1.397-399.1977

10.1111/j.1348-0421.1980.tb02860.x

10.1099/00221287-46-1-143

Geoffroy C., 1983, J. Biol. Chem., 258, 9968, 10.1016/S0021-9258(17)44592-3

Cowell J. L., 1976, Infect. Immun., 14, 144, 10.1128/iai.14.1.144-154.1976

Epps D. E., 1971, Infect. Immun., 3, 648, 10.1128/iai.3.5.648-652.1971

Mitsui K., 1973, Jpn J. Exp. Med., 43, 377

Johnson M. K., 1972, Infect. Immun., 6, 755, 10.1128/iai.6.5.755-760.1972

10.1016/0005-2795(77)90159-3

Geoffroy C., 1981, Biochem. Biophys. Res. Commun., 99, 781, 10.1016/0006-291X(81)91233-X

10.1021/bi00368a032

Ellman G. L., 1959, Arch. Biochem. Biophys., 126, 155

10.1016/S0021-9258(19)43393-0

10.1038/227680a0

Mayer M. M., 1961, Kabat and Mayer's experimental immunochemistry, 133

Nelson G. J., 1972, Blood lipids and lipoproteins: Quantitation, composition, and metabolism, 317

10.1016/0041-0101(82)90208-2

Kanbayashi Y., 1972, J. Biochem. (Tokyo), 71, 227, 10.1093/oxfordjournals.jbchem.a129759